Molecular Mechanism of Pathogenesis

发病机制的分子机制

基本信息

  • 批准号:
    7393692
  • 负责人:
  • 金额:
    $ 34.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-05-15 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A Yersinia effector known as YopT and a Pseudomonas avirulence protein known as AvrPphB define a family of 19 proteins involved in bacterial pathogenesis. We show that both YopT and AvrPphB are cysteine proteases, and their proteolytic activities are dependent upon the invariant C/HID residues conserved in the entire YopT family. YopT cleaves the post-translationally modified Rho GTPases near their carboxyl termini, releasing them from the membrane. This leads to the disruption of actin cytoskeleton in host cells. The proteolytic activity of AvrPphB is essential for autoproteolytic cleavage of an AvrPphB precursor as well as for eliciting the hypersensitive response in plants. The biochemical functions of most avirulence (Avr) proteins are unknown. This proposal focuses on developing a molecular understanding of how the AvrPphB family of proteins is activated and post-translationally modified. In addition, efforts to identify the substrate(s) for AvrPphB are described. Finally, we propose to obtain the x-ray structure of AvrPphB complexed with a peptide substrate. These experiments will provide us with new insights into the molecular mechanism of pathogenesis.
描述(由申请人提供):耶尔森氏菌效应子(称为YopT)和假单胞菌无毒蛋白(称为AvrPphB)定义了一个涉及细菌发病机制的19种蛋白质家族。我们表明,YopT和AvrPphB是半胱氨酸蛋白酶,它们的蛋白水解活性依赖于在整个YopT家族中保守的不变C/HID残基。YopT在其羧基末端附近切割后修饰的Rho GTP酶,将其从膜释放。这导致宿主细胞中肌动蛋白细胞骨架的破坏。AvrPphB的蛋白水解活性对于AvrPphB前体的自蛋白水解切割以及引发植物中的过敏反应是必不可少的。大多数无毒(Avr)蛋白的生化功能是未知的。该提案的重点是开发AvrPphB蛋白家族如何被激活和后修饰的分子理解。此外,还描述了鉴定AvrPphB底物的努力。最后,我们建议获得与肽底物复合的AvrPphB的X射线结构。这些实验将为我们提供新的见解发病的分子机制。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A family of bacterial cysteine protease type III effectors utilizes acylation-dependent and -independent strategies to localize to plasma membranes.
  • DOI:
    10.1074/jbc.m900519200
  • 发表时间:
    2009-06-05
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Dowen RH;Engel JL;Shao F;Ecker JR;Dixon JE
  • 通讯作者:
    Dixon JE
Subversion of myosin function by E. coli.
大肠杆菌破坏肌球蛋白功能。
  • DOI:
    10.1016/j.devcel.2007.12.016
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    Mattoo,Seema;Alto,NealM;Dixon,JackE
  • 通讯作者:
    Dixon,JackE
Protection of mice against H. somni septicemia by vaccination with recombinant immunoglobulin binding protein subunits.
通过接种重组免疫球蛋白结合蛋白亚基来保护小鼠免受睡眠嗜血菌败血症。
  • DOI:
    10.1016/j.vaccine.2008.06.046
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Geertsema,RogerS;Worby,Carolyn;Kruger,RobertP;Tagawa,Yuichi;Russo,Riccardo;Herdman,DScott;Lo,Kimby;Kimball,RichardA;Dixon,Jack;Corbeil,LynetteB
  • 通讯作者:
    Corbeil,LynetteB
Structural basis of Fic-mediated adenylylation.
The fic domain: regulation of cell signaling by adenylylation.
  • DOI:
    10.1016/j.molcel.2009.03.008
  • 发表时间:
    2009-04-10
  • 期刊:
  • 影响因子:
    16
  • 作者:
    Worby, Carolyn A.;Mattoo, Seema;Kruger, Robert P.;Corbeil, Lynette B.;Koller, Antonius;Mendez, Juan C.;Zekarias, Bereket;Lazar, Cheri;Dixon, Jack E.
  • 通讯作者:
    Dixon, Jack E.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JACK E DIXON其他文献

JACK E DIXON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JACK E DIXON', 18)}}的其他基金

Lafora epilepsy mechanisms: insights into brain metabolism
拉福拉癫痫机制:深入了解大脑代谢
  • 批准号:
    9125528
  • 财政年份:
    2016
  • 资助金额:
    $ 34.74万
  • 项目类别:
CHARACTERIZE THE FUNCTION OF PROTEIN TYROSINE PHOSPHATASE PTPMT1 IN MITOCHONDRIA
表征蛋白质酪氨酸磷酸酶 PTPMT1 在线粒体中的功能
  • 批准号:
    8361936
  • 财政年份:
    2011
  • 资助金额:
    $ 34.74万
  • 项目类别:
ASSIGNMENT OF POSTTRANSLATIONAL MODIFICATIONS IN STREPTOLYSIN-S ANALOGUE
链球菌溶血素-S 类似物中翻译后修饰的分配
  • 批准号:
    8168991
  • 财政年份:
    2010
  • 资助金额:
    $ 34.74万
  • 项目类别:
Phosphoinositide Phosphatases
磷酸肌醇磷酸酶
  • 批准号:
    8036713
  • 财政年份:
    2010
  • 资助金额:
    $ 34.74万
  • 项目类别:
YopT: A Yersinia Virulence Factor
YopT:耶尔森菌毒力因子
  • 批准号:
    7052060
  • 财政年份:
    2005
  • 资助金额:
    $ 34.74万
  • 项目类别:
YopT: A Yersinia Virulence Factor
YopT:耶尔森菌毒力因子
  • 批准号:
    6907659
  • 财政年份:
    2005
  • 资助金额:
    $ 34.74万
  • 项目类别:
Fic-mediated Adenylylation
Fic介导的腺苷酸化
  • 批准号:
    8509713
  • 财政年份:
    2004
  • 资助金额:
    $ 34.74万
  • 项目类别:
Molecular Mechanism of Pathogenesis
发病机制的分子机制
  • 批准号:
    6894645
  • 财政年份:
    2004
  • 资助金额:
    $ 34.74万
  • 项目类别:
Molecular Mechanism of Pathogenesis
发病机制的分子机制
  • 批准号:
    6802631
  • 财政年份:
    2004
  • 资助金额:
    $ 34.74万
  • 项目类别:
Molecular Mechanism of Pathogenesis
发病机制的分子机制
  • 批准号:
    7058321
  • 财政年份:
    2004
  • 资助金额:
    $ 34.74万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.74万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了